LCGC North America
This Application Note demonstrates the separation and quantification of beta-blockers, listed as prohibited substances by the World Anti-Doping Agency, in urine using the Agilent 1260 Infinity Analytical SFC System.
Bernhard Wuest
Advertisement
Articles by Bernhard Wuest
LCGC Europe
This Application Note demonstrates the separation and quantification of beta-blockers, listed as prohibited substances by the World Anti-Doping Agency, in urine using the Agilent 1260 Infinity Analytical SFC System.
Advertisement
Latest Updated Articles
- Determination of Beta-Blockers in Urine Using SFC/MS
March 24th 2016
- Determination of Beta-Blockers in Urine Using SFC/MS
March 24th 2016
Advertisement
Advertisement
Trending on LCGC International
1
Fast Low-Pressure Chiral GC for Pesticides in Wine
2
Industry Roundup: Air Products Advances Gas Chromatography Performance
3
AI/ML Now: Hybrid Machine Learning for Experiment-Efficient HPLC
4
AI/ML Now: Bringing Autonomous Digital Twin Workflows Into the Laboratory
5